US 6224866
Immunotherapy of B cell involvement in progression of solid, nonlymphoid tumors
expired A61KA61K2039/505A61K39/395
Quick answer
US patent 6224866 (Immunotherapy of B cell involvement in progression of solid, nonlymphoid tumors) held by BioCrystal, Ltd. expires Mon Apr 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- BioCrystal, Ltd.
- Grant date
- Tue May 01 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 46
- CPC classes
- A61K, A61K2039/505, A61K39/395